Project Grant R01DK146067
- Federal Project Grant Award Summary Emory University received a $430,375 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 19, 2025, through September 18, 2027. The award funds research utilizing an ex vivo rectal explant challenge model to evaluate HIV-1 transmitted/founder virus replication and associated inflammatory responses...
- Federal Grant Award Summary The Broad Institute, Inc. received an $882,180 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) awarded on September 19, 2025, with completion targeted for May 31, 2030. This award supports massive-scale genomic risk assessment research to advance precision medicine across the spectrum of monogenic and common forms of diabetes....
- Federal Project Grant Award Summary Emory University received a $1,108,022 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 25, 2025, through January 31, 2030. The award funds the CARE-D-FOOT-NAV (Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation) randomized controlled trial, which will develop and...
- Project Grant Summary Emory University received a $802,363 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 18, 2025, through June 30, 2030. The research project, "From Evidence to Policy: Tailoring GLP-1RA Coverage for Optimal Health Outcomes," will develop analytical and computational tools to inform precision health...
- Federal Grant Award Summary Emory University received a $384,414 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2025, through March 31, 2029. The grant supports basic biomedical research investigating the electrostatic interactions among the epithelial sodium channel (ENaC), MARCKS-like protein-1 (MLP-1), and phosphatidylinositol...
- Federal Grant Award Summary Albert Einstein College of Medicine received $887,696 in funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a project grant awarded February 1, 2026, with completion targeted for November 30, 2030. The project will profile plasma proteome data on over 5,000 proteins using OLink Explore HT technology in approximately 2,300...
- Federal Project Grant Award Summary The Johns Hopkins University received a $819,091 Project Grant award dated September 11, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports research extending through June 30, 2030, to investigate glucose patterns and clinical outcomes in the Dallas Heart Study cohort using continuous glucose monitoring (CGM)...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $786,216 Project Grant to the University of California, Los Angeles (UCLA) on August 28, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This four-year research initiative, concluding June 30, 2029, supports fundamental biomedical research investigating the post-transcriptional regulation of hepatokines and their role in systemic...
- Summary of Federal Project Grant Award The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded UCLA a $1,089,491 project grant effective March 10, 2025, through February 28, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds the development of novel statistical methods, computational algorithms, and user-friendly software tools designed to analyze individual health trajectories and predict disease...
- Federal Grant Award Summary The University of Pennsylvania received a $787,367 project grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 9, 2025, with completion targeted for June 30, 2030. This award supports the development of comprehensive mapping of pancreatic islet cell types and their gene regulatory architecture to advance diabetes...
Emory University received a $824,296 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 1, 2026, with completion targeted for December 31, 2030. The award supports the "Putting Phenotypes and Polygenics Into Practice for Diabetes Care (4PDC)" research initiative, which will deliver comprehensive research services aimed at addressing Type 2 Diabetes (T2D) heterogeneity through advanced phenotypic classification and genomic analysis. The project will produce evidence-based research products including novel T2D phenotypes derived from widely available clinical variables sourced from approximately 110,434 individuals across eight U.S. states within the Kaiser Permanente Research Bank cohort. Through longitudinal assessment over a 13-year mean follow-up period, the research will deliver insights into T2D phenotype dynamics, disease progression related to aging, and associations with T2D complications. The study will employ advanced data-driven clustering techniques and integrate polygenic risk score analysis to advance understanding of biological mechanisms driving heterogeneous T2D presentations, with particular focus on improving generalizability across diverse populations and capturing dynamic changes in disease phenotypes over time.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $824.3k | 2/3/26 |